Search

everythinglearnresearchcommunity

for

Search:↓

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

New technologies help us better understand how skin microbes affect skin diseases.

Iron deficiency might contribute to hair loss in women.

A man had temporary hair loss from radiation during a medical procedure but regrew his hair after treatment with minoxidil lotion.

Low-Level Light Therapy is effective for skin rejuvenation, wound healing, and hair growth, with mild side effects.

Effective treatment for hidradenitis suppurativa varies, with antibiotics commonly used and surgery as an option, but no single method is universally successful.

The document explains the genetic causes and characteristics of inherited hair disorders.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

43.1% of rabbits in Mosul City had mange, with Sarcoptes scabiei var. cuniculi being the most common.

Netherton syndrome can cause severe dehydration, infections, and growth issues in infants.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Female pattern hair loss is common and should be treated early to prevent worsening, with Minoxidil being the main approved treatment.

More research is needed to find effective treatments for Female Pattern Hair Loss.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

A specific hair diffraction pattern may indicate breast cancer if tested with the correct method.

Tamoxifen caused hair loss in a 52-year-old woman.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.